Annual Accounts Payable
$11.12 M
-$873.00 K-7.28%
December 31, 2023
Summary
- As of February 7, 2025, VERA annual accounts payable is $11.12 million, with the most recent change of -$873.00 thousand (-7.28%) on December 31, 2023.
- During the last 3 years, VERA annual accounts payable has risen by +$10.21 million (+1123.10%).
- VERA annual accounts payable is now -7.28% below its all-time high of $11.99 million, reached on December 31, 2022.
Performance
VERA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.60 M
-$62.00 K-1.33%
September 30, 2024
Summary
- As of February 7, 2025, VERA quarterly accounts payable is $4.60 million, with the most recent change of -$62.00 thousand (-1.33%) on September 30, 2024.
- Over the past year, VERA quarterly accounts payable has dropped by -$6.52 million (-58.61%).
- VERA quarterly accounts payable is now -72.77% below its all-time high of $16.90 million, reached on March 31, 2020.
Performance
VERA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VERA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.3% | -58.6% |
| 3 y3 years | +1123.1% | +377.4% |
| 5 y5 years | +3150.9% | -72.8% |
VERA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.3% | +702.7% | -65.3% | +232.3% |
| 5 y | 5-year | -7.3% | +3150.9% | -72.8% | +406.3% |
| alltime | all time | -7.3% | +3150.9% | -72.8% | +406.3% |
Vera Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.60 M(-1.3%) |
| Jun 2024 | - | $4.66 M(-10.5%) |
| Mar 2024 | - | $5.21 M(-53.1%) |
| Dec 2023 | $11.12 M(-7.3%) | $11.12 M(-9.6%) |
| Sep 2023 | - | $12.30 M(-7.4%) |
| Jun 2023 | - | $13.28 M(+149.3%) |
| Mar 2023 | - | $5.33 M(-55.6%) |
| Dec 2022 | $11.99 M | $11.99 M(+71.0%) |
| Sep 2022 | - | $7.01 M(-1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $7.08 M(-3.3%) |
| Mar 2022 | - | $7.33 M(+429.1%) |
| Dec 2021 | $1.39 M(+52.4%) | $1.39 M(+43.7%) |
| Sep 2021 | - | $964.00 K(-44.1%) |
| Jun 2021 | - | $1.72 M(+19.7%) |
| Mar 2021 | - | $1.44 M(+58.4%) |
| Dec 2020 | $909.00 K(+165.8%) | - |
| Dec 2020 | - | $909.00 K(-94.6%) |
| Mar 2020 | - | $16.90 M |
| Dec 2019 | $342.00 K | - |
FAQ
- What is Vera Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Vera Therapeutics?
- What is Vera Therapeutics annual accounts payable year-on-year change?
- What is Vera Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Vera Therapeutics?
- What is Vera Therapeutics quarterly accounts payable year-on-year change?
What is Vera Therapeutics annual accounts payable?
The current annual accounts payable of VERA is $11.12 M
What is the all time high annual accounts payable for Vera Therapeutics?
Vera Therapeutics all-time high annual accounts payable is $11.99 M
What is Vera Therapeutics annual accounts payable year-on-year change?
Over the past year, VERA annual accounts payable has changed by -$873.00 K (-7.28%)
What is Vera Therapeutics quarterly accounts payable?
The current quarterly accounts payable of VERA is $4.60 M
What is the all time high quarterly accounts payable for Vera Therapeutics?
Vera Therapeutics all-time high quarterly accounts payable is $16.90 M
What is Vera Therapeutics quarterly accounts payable year-on-year change?
Over the past year, VERA quarterly accounts payable has changed by -$6.52 M (-58.61%)